(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Must-See Public Parks from Around the Globe - 2Figure out How to Reveal Stowed away Open Record Rewards
- 3RFK Jr.'s diet guidelines emphasize red meat, full-fat dairy. How healthy are they?
- 4Raw oysters linked to ongoing salmonella outbreak infecting 64 across 22 states: CDC
- 5Curl Up With Some Hot Chocolate And Watch Mighty Car Mods Explore Japan In A Honda City Turbo II
- Warnings rise for U.S. as severe flu strain causes outbreaks in Canada, U.K.
- 'Peaky Blinders: The Immortal Man' teaser trailer reveals Cillian Murphy's Tommy Shelby back in action
- Share your pick for the tree that you love for its novel magnificence!
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
- Meet Beef the bulldog, who takes slow walks with his 78-year-old friend
- Somaliland denies trading recognition with Israel for accepting Gazans
- Mystery foot suggests a second early human relative lived alongside Lucy
- Israeli Chief of Staff declares new border with Gaza Strip
- A Manual for Nations to Head out To
